Search clinical trials for: Propellant

Total 27 results

GlaxoSmithKline

Recruiting

A Study to Compare Safety of 4 Weeks Exposure to Propellants Hydrofluoroalkane 1,1-difluoroethane (HFA-152a) and HFA-1,1,1,2-tetrafluoroethane (134a)

Asthma

United States, Canada, Argentina, United Kingdom
GlaxoSmithKline

Recruiting

A Study to Compare the Relative Potency of Salbutamol Administered Via Metered Dose Inhalers (MDI) Containing Propellants HFA-152a to HFA-134a in Mild Asthmatics Aged 18 to 65 Inclusive

Asthma | Mild Asthma

United Kingdom
GlaxoSmithKline

Completed

A Study to Assess and Compare Safety and Tolerability of 3 Months Treatment With Salbutamol Administered Via MDI Containing Propellant HFA-152a or HFA-134a in Participants ≥ 18 Years of Age With Asthma

Asthma

United States, Argentina, Canada, Spain, Philippines, Greece, France, Poland, United Kingdom, Australia, Italy, Thailand, Panama
AstraZeneca

Completed

A Study to Investigate the Effect on Lung Function of BDA Formulated With a Next Generation Propellant Compared With an Approved Asthma Treatment (BDA With HFA Propellant) in Participants With Asthma

Asthma

United States, Thailand, Vietnam, China, Mexico, Malaysia
GlaxoSmithKline

Completed

A Study to Assess the Potential for Airway Sensitivity Reactions With Propellants HFA-152a (Test) and HFA-134a (Reference) Administered Via Pressurized Inhalers in Adults With Mild Asthma

Asthma

United States

This is a preview

Log in or create a free account to see all matching trials and use the full search.

Log in Register

Subscribe